182 related articles for article (PubMed ID: 9423168)
1. Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis.
Ramaiya A; Johnson JH; Karnes HT
J Pharm Sci; 1997 Dec; 86(12):1497-500. PubMed ID: 9423168
[TBL] [Abstract][Full Text] [Related]
2. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
3. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.
David DJ; Bourin M; Jego G; Przybylski C; Jolliet P; Gardier AM
Br J Pharmacol; 2003 Nov; 140(6):1128-36. PubMed ID: 14530210
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis.
Malagié I; Deslandes A; Gardier AM
Eur J Pharmacol; 2000 Sep; 403(1-2):55-65. PubMed ID: 10969144
[TBL] [Abstract][Full Text] [Related]
6. Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine.
Hajós-Korcsok E; McTavish SF; Sharp T
Eur J Pharmacol; 2000 Oct; 407(1-2):101-7. PubMed ID: 11050296
[TBL] [Abstract][Full Text] [Related]
7. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
Beyer CE; Boikess S; Luo B; Dawson LA
J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
[TBL] [Abstract][Full Text] [Related]
9. Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex.
Nakayama K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):102-5. PubMed ID: 11819027
[TBL] [Abstract][Full Text] [Related]
10. [Paroxetine (paxil): use in clinical practice].
Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
[No Abstract] [Full Text] [Related]
11. Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levels.
Licht CL; Knudsen GM; Sharp T
Neurosci Lett; 2010 May; 476(2):58-61. PubMed ID: 20381585
[TBL] [Abstract][Full Text] [Related]
12. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
13. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.
Kitaichi Y; Inoue T; Nakagawa S; Boku S; Kakuta A; Izumi T; Koyama T
Eur J Pharmacol; 2010 Nov; 647(1-3):90-6. PubMed ID: 20816814
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.
Malagié I; Trillat AC; Bourin M; Jacquot C; Hen R; Gardier AM
J Neurochem; 2001 Feb; 76(3):865-71. PubMed ID: 11158258
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine: a review.
Bourin M; Chue P; Guillon Y
CNS Drug Rev; 2001; 7(1):25-47. PubMed ID: 11420571
[TBL] [Abstract][Full Text] [Related]
17. Brain creatine kinase activity is increased by chronic administration of paroxetine.
Santos PM; Scaini G; Rezin GT; Benedet J; Rochi N; Jeremias GC; Carvalho-Silva M; Quevedo J; Streck EL
Brain Res Bull; 2009 Dec; 80(6):327-30. PubMed ID: 19772902
[TBL] [Abstract][Full Text] [Related]
18. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
Nadgir SM; Malviya M
Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
Hjorth S; Auerbach SB
Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
[TBL] [Abstract][Full Text] [Related]
20. S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
Millan MJ; Dekeyne A; Gobert A; Mannoury la Cour C; Brocco M; Rivet JM; Di Cara B; Lejeune F; Cremers TI; Flik G; de Jong TR; Olivier B; de Nanteuil G
Eur Neuropsychopharmacol; 2010 Sep; 20(9):599-621. PubMed ID: 20483567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
